| 14C-ARN-509 Microtracer Label AME and Absolute BA Study (NCT01822041) | Aragon Pharmaceuticals, Inc. | 2013-03-01 |
| The Impact of Proton Pump Inhibitors on the Fecal Microbiome (NCT01822977) | Mayo Clinic | 2013-03-01 |
| The Role of the Microbiota in the Systemic Immune Response (NCT02340182) | W.J. Wiersinga, MD, PhD | 2013-03-01 |
| IPI-145 ADME and Absolute Bioavailability Study (NCT01836861) | SecuraBio | 2013-03-01 |
| A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation (NCT01821079) | Pfizer | 2013-03-01 |
| Pharmacokinetics and Pharmacodynamics Study of BCD-066 Compared to Aranesp® in Healthy Volunteers (NCT02506881) | Biocad | 2013-03-01 |
| Pharmacokinetics of Faldaprevir of Soft Capsule (NCT01821937) | Boehringer Ingelheim | 2013-03-01 |
| PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects. (NCT01685333) | Azidus Brasil | 2013-02-28 |
| Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration (NCT01692171) | Azidus Brasil | 2013-02-28 |
| PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant (NCT01685359) | Azidus Brasil | 2013-02-28 |
| Interactive Effects of IV Ethanol and IV Nicotine (NCT01814410) | Yale University | 2013-02-22 |
| Regulation of Intestinal and Hepatic Lipoprotein Particle Production by Blood Glucose in Humans (NCT02607839) | University Health Network, Toronto | 2013-02-01 |
| PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects. (NCT01664221) | Azidus Brasil | 2013-02-01 |
| An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment (NCT01790607) | Ono Pharma USA Inc | 2013-02-01 |
| Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects (NCT01768455) | LG Life Sciences | 2013-02-01 |
| Safety Study on IdeS in Healthy Volounteers (NCT01802697) | Hansa Biopharma AB | 2013-02-01 |
| ANX-188 Thorough QT/QTc Study in Healthy Volunteers (NCT01790087) | Mast Therapeutics, Inc. | 2013-02-01 |
| PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS (NCT01652638) | Azidus Brasil | 2013-02-01 |
| PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases (NCT01805635) | Medical University of Lodz | 2013-02-01 |
| The Safety of Tuberculosis Treatments by Oral Inhalation (NCT01785927) | Prince of Songkla University | 2013-02-01 |
| A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers (NCT01746901) | Pfizer | 2013-02-01 |
| PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects (NCT01664195) | Azidus Brasil | 2013-02-01 |
| PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS (NCT01651923) | Azidus Brasil | 2013-02-01 |
| Investigation of Faldaprevir Effect on Pharmacokinetics of Raltegravir (NCT01785160) | Boehringer Ingelheim | 2013-02-01 |
| A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007 (NCT01929070) | Hanmi Pharmaceutical Company Limited | 2013-02-01 |
| Training Study to Characterise Biomarkers to the Engerix B Vaccine (NCT01771354) | University of Surrey | 2013-02-01 |
| The Effect of Mixed Exercise and Metabolic Stress in Relationship to Age in Healthy Men (NCT01800370) | Mayo Clinic | 2013-02-01 |
| Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin (NCT01795937) | Boehringer Ingelheim | 2013-02-01 |
| A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations (NCT02249936) | Ardelyx | 2013-02-01 |
| Creatine Supplementation on Cognition in Children (NCT01803230) | University of Sao Paulo | 2013-02-01 |
| 240 mL Water Drink Study (NCT01792453) | University of Nottingham | 2013-02-01 |
| TopQ Cut-Off Determination Study (NCT01824784) | Topcon Medical Systems, Inc. | 2013-02-01 |
| Study of Muscle Repair Following Exercise in Young and Elderly People (NCT02174692) | University of Nottingham | 2013-02-01 |
| Effect of B-GOS on GI Discomfort in Healthy Adults (NCT01824667) | Clasado Limited | 2013-02-01 |
| Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers (NCT01766024) | Biocad | 2013-02-01 |
| Non-erythroid Effects of Erythropoietin on Cognitive Function and Exercise Capacity in Humans (NCT01889056) | University of Zurich | 2013-02-01 |
| Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid. (NCT01808300) | Unimed Pharmaceuticals | 2013-02-01 |
| A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA) (NCT02529787) | Genuine Research Center, Egypt | 2013-02-01 |
| Bioequivalence Study of Two Formulations of 10 mg Lisinopril Tablet Under Fasting Condition (NCT01936012) | Dexa Medica Group | 2013-02-01 |
| Nutritional Metabolomics: the Search for Dietary Exposure Variables 2 (NCT02039609) | Göteborg University | 2013-02-01 |
| Comparison of the Prediction Derived by the Cardiovascular Performance Reserve Index With the Clinical Evaluation (NCT01796704) | Clalit Health Services | 2013-02-01 |
| Investigating the Effects of a High GI Versus a Low GI Diet on Hepatic Metabolism and Satiety Levels in Healthy Subjects (NCT02482558) | Unilever R&D | 2013-02-01 |
| A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted (NCT01775189) | Pfizer | 2013-02-01 |
| A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects (NCT01798979) | Lakefront Biotherapeutics NV | 2013-02-01 |
| Functional Magnetic Resonance Imaging of Human Hypothalamic Responses to Oral Temperature and Glucose Sensing (NCT03181217) | Unilever R&D | 2013-01-28 |
| Alternation in the Human Microbiome With Commonly Used Topical Medications (NCT03437005) | University of California, Davis | 2013-01-28 |
| Auditory Deficits in Congenital Amusia (AMUSIE CONGENITALE) (NCT03094624) | Hospices Civils de Lyon | 2013-01-13 |
| Neuralized1 and RGS14 Genes (NCT04865198) | TC Erciyes University | 2013-01-10 |
| Organization of the Cingulate Cortex (NCT03119870) | Hospices Civils de Lyon | 2013-01-09 |
| To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706 (NCT01763333) | Boehringer Ingelheim | 2013-01-08 |
| A Single-dose Study in Healthy Japanese Male Adults to Evaluate Pharmacokinetics and Pharmacodynamics of E5501 5 mg Tablet (Study E5501-J081-015) (NCT01774773) | Eisai Co., Ltd. | 2013-01-01 |
| Influence of Bupropion on the Effects of MDMA (NCT01771874) | University Hospital, Basel, Switzerland | 2013-01-01 |
| Effects of Gastric pH on the Pharmacokinetics of Atazanavir (NCT01759875) | University of California, San Francisco | 2013-01-01 |
| AME Study of [14C]-YH4808 in Healthy Male Subjects (NCT01825707) | Yuhan Corporation | 2013-01-01 |
| Open Label Study Evaluating the Effects of a Single Oritavancin Infusion on Cytochrome P450 in Healthy Volunteers (NCT01784536) | Melinta Therapeutics, Inc. | 2013-01-01 |
| Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine. (NCT02013245) | Biofabri, S.L | 2013-01-01 |
| Manual Diaphragm Release Technique Effects On Tidal Volume in Elderly (NCT01975740) | Universidade Federal de Pernambuco | 2013-01-01 |
| Comparison of Two Devices Using Near-infra Red Spectroscopy During a Vascular Occlusion Test (NCT01848977) | Seoul National University Hospital | 2013-01-01 |
| The Effects of General Anesthetics on Upper Airway Collapsibility in Healthy Subjects (NCT01557920) | Massachusetts General Hospital | 2013-01-01 |
| Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin (NCT01770392) | Boehringer Ingelheim | 2013-01-01 |
| The Effect of Constructing Virtual Patient Cases (NCT02400606) | Rigshospitalet, Denmark | 2013-01-01 |
| Effect of Vitamin B12 and n-3 Polyunsaturated Fatty Acids on Plasma Homocysteine (NCT01762072) | Zhejiang University | 2013-01-01 |
| Food-Effect on PK and PD of Single Oral Dose of CJ-12420 in Healthy Male Subjects (NCT01830309) | HK inno.N Corporation | 2013-01-01 |
| Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects (NCT01794364) | Pfizer | 2013-01-01 |
| High Intensity Interval Training in 1% or 10% Slope (NCT02511964) | Universidade Federal do Rio de Janeiro | 2013-01-01 |
| A Single-Radiolabeled Dose Mass Balance Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] Palbociclib (PD-0332991) In Healthy Male Volunteers (NCT01756768) | Pfizer | 2013-01-01 |
| Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects (NCT01787032) | Boehringer Ingelheim | 2013-01-01 |
| Metabolic Effects of Honey or Fructose:Glucose Mixtures (NCT02747446) | Luc Tappy, MD | 2013-01-01 |
| Safety And Tolerability Study Of BID Titration Scheme With PF-05089771 (NCT01772264) | Pfizer | 2013-01-01 |
| Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors (NCT01778686) | Gitte Moos Knudsen | 2013-01-01 |
| Therapeutic Drug Monitoring and Pharmacokinetic Compartmental Analysis of Sulpiride After Oral Administration to Healthy Volunteers (NCT01777685) | Damanhour University | 2013-01-01 |
| A Phase I Study of Oral UE2343 in Healthy Subjects (NCT01770886) | University of Edinburgh | 2013-01-01 |
| Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM) (NCT02114957) | Texas Tech University Health Sciences Center | 2013-01-01 |
| A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo (NCT02644135) | University Hospitals Cleveland Medical Center | 2013-01-01 |
| Donepezil Effect on Visual Attention and Training (NCT01738295) | Université de Montréal | 2013-01-01 |
| Impact of Formulation on Ciprofloxacin Oral Absorption (NCT00992329) | University of Maryland, Baltimore | 2013-01-01 |
| Training Study to Characterize Biomarkers to Flu Vaccines (NCT01771367) | University of Surrey | 2013-01-01 |
| Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions (NCT01764945) | Boehringer Ingelheim | 2013-01-01 |
| A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants (NCT01762839) | Melinta Therapeutics, Inc. | 2012-12-27 |
| A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A (NCT01724814) | Hanmi Pharmaceutical Company Limited | 2012-12-20 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy (NCT01751776) | Boehringer Ingelheim | 2012-12-18 |
| A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine (NCT02692170) | Aribio Lab Co., Ltd. | 2012-12-07 |
| Hemodynamic Responses During Induction: Comparison of Marsh and Schnider Pharmacokinetic Models (NCT01759160) | First Affiliated Hospital, Sun Yat-Sen University | 2012-12-01 |
| Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions (NCT01910090) | Pharmaceutical Research Unit, Jordan | 2012-12-01 |
| Environments as Smoking Cues: Imaging Brain Substrates, Developing New Treatments (CameraCue) (NCT01840111) | Duke University | 2012-12-01 |
| A Study to Assess the Bioequivalence of a New ULTRACET Extended Release (ER) Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition (NCT01778075) | Janssen Korea, Ltd., Korea | 2012-12-01 |
| Predicting Central Pain Among People With a Spinal Cord Injury by Evaluating Mechanisms Regulating Pain and Efficacy Testing of the TENS Apparatus (NCT01726881) | Sheba Medical Center | 2012-12-01 |
| Determinants of Formate Concentrations (NCT03305900) | Memorial University of Newfoundland | 2012-12-01 |
| Genetic Variability in Taste Perception (NCT01841710) | Monell Chemical Senses Center | 2012-12-01 |
| A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder (NCT01774747) | Sumitomo Pharma America, Inc. | 2012-12-01 |
| Fructose and Ethnic Differences Study (FED Study) (NCT02533817) | King's College London | 2012-12-01 |
| A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function (NCT01761773) | Exelixis | 2012-12-01 |
| Pharmacokinetic Study of CXB909 in Healthy Male Subjects (NCT01505907) | CeNeRx BioPharma Inc. | 2012-12-01 |
| The Potential for Pomegranate Juice to Ameliorate Endothelial Dysfunction (NCT01748617) | Janet Novotny | 2012-12-01 |
| Development of Novel Designed Force Plate for Measuring the Balance Ability for the Elders (NCT02615028) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2012-12-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers (NCT02746302) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2012-12-01 |
| A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes (NCT01766245) | Novo Nordisk A/S | 2012-12-01 |
| Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers (NCT01741519) | AOP Orphan Pharmaceuticals AG | 2012-12-01 |
| The Conversion of ENcapsulated GlucorAphanin, Gut Microbiota Phylogeny and gEnotype Study (ENGAGE) (NCT01927666) | Quadram Institute Bioscience | 2012-12-01 |
| Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones (NCT01795235) | University of Virginia | 2012-12-01 |